학술논문
110 Tumor clone frequency is a robust predictor of progression and survival in patients with Stage IB mycosis fungoides
Document Type
Abstract
Author
Source
In Journal of Investigative Dermatology May 2018 138(5) Supplement:S19-S19
Subject
Language
ISSN
0022-202X